The global next-generation sequencing (NGS) services market is expected to grow at a CAGR of 16.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for personalized medicine and rising incidence of cancer cases. The NGS services market has been segmented on the basis of type, application, and region. On the basis of type, it has been classified into SBS, ion semiconductor sequencing (ISS), SBL, PyrSequencing and SMRT sequencing technologies. On the basis of application, it has been classified into oncology applications such as lung cancer diagnosis and breast cancer diagnosis; lung cancer treatment; prostate cancer diagnosis; colorectal cancer diagnosis; colorectal cancer treatment; breast cancer treatment; prostate cancer treatment and other applications such as infectious disease diagnostics. On the basis of region it has been classified into North America (NA), Latin America (LA), Europe (EU), Asia Pacific & Middle East & Africa (APMEA).
Some Of The Growth Factors Of This Market:
- The market for NGS Services is expected to be worth $6,890 million by 2022.
- Increasing demand for personalized medicine and genetic testing services are the major drivers of the growth in this market.
- Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases are also driving the growth in this market.
- Increasing government funding for research and development activities related to genomics.
Industry Growth Insights published a new data on “NGS Services Market”. The research report is titled “NGS Services Market research by Types (SBS, Ion Semiconductor, SBL, Pyro-Sequencing, SMRT), By Applications (Oncology, Lung cancer, Breast cancer, Prostate cancer, Colorectal cancer, Others), By Players/Companies Beijing Genomics Institute (BGI), Cegat (Centre for Genomics and Transcriptomics) GMBH, DNA Vision SA, Eurofins Genomics Inc., Febit / Comprehensive Biomarker Center GMBH (CBC), Genomnia SRL, Mina Inc., Macrogen Inc., Microsynth AG, Seqomics, Source Bio Science”.
Scope Of The Report
Report Attributes
Report Details
Report Title
NGS Services Market Research Report
By Type
SBS, Ion Semiconductor, SBL, Pyro-Sequencing, SMRT
By Application
Oncology, Lung cancer, Breast cancer, Prostate cancer, Colorectal cancer, Others
By Companies
Beijing Genomics Institute (BGI), Cegat (Centre for Genomics and Transcriptomics) GMBH, DNA Vision SA, Eurofins Genomics Inc., Febit / Comprehensive Biomarker Center GMBH (CBC), Genomnia SRL, Mina Inc., Macrogen Inc., Microsynth AG, Seqomics, Source Bio Science
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global NGS Services Market Report Segments:
The global NGS Services market is segmented on the basis of:
Types
SBS, Ion Semiconductor, SBL, Pyro-Sequencing, SMRT
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Lung cancer, Breast cancer, Prostate cancer, Colorectal cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Beijing Genomics Institute (BGI)
- Cegat (Centre for Genomics and Transcriptomics) GMBH
- DNA Vision SA
- Eurofins Genomics Inc.
- Febit / Comprehensive Biomarker Center GMBH (CBC)
- Genomnia SRL
- Mina Inc.
- Macrogen Inc.
- Microsynth AG
- Seqomics
- Source Bio Science
Highlights of The NGS Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- SBS
- Ion Semiconductor
- SBL
- Pyro-Sequencing
- SMRT
- By Application:
- Oncology
- Lung cancer
- Breast cancer
- Prostate cancer
- Colorectal cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the NGS Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
NGS Services is a suite of software that provides genome sequencing and analysis services. It includes the Genome Analysis Toolkit (GATK), which is a collection of tools for sequence data analysis, and the Sequence Read Archive (SRA), which stores raw sequencing data. NGS Services also includes the BioMart platform, which helps researchers manage their genomic research projects.
Some of the key players operating in the ngs services market are Beijing Genomics Institute (BGI), Cegat (Centre for Genomics and Transcriptomics) GMBH, DNA Vision SA, Eurofins Genomics Inc., Febit / Comprehensive Biomarker Center GMBH (CBC), Genomnia SRL, Mina Inc., Macrogen Inc., Microsynth AG, Seqomics, Source Bio Science.
The ngs services market is expected to register a CAGR of 16.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. NGS Services Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. NGS Services Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. NGS Services Market - Supply Chain
4.5. Global NGS Services Market Forecast
4.5.1. NGS Services Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. NGS Services Market Size (000 Units) and Y-o-Y Growth
4.5.3. NGS Services Market Absolute $ Opportunity
5. Global NGS Services Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. NGS Services Market Size and Volume Forecast by Type
5.3.1. SBS
5.3.2. Ion Semiconductor
5.3.3. SBL
5.3.4. Pyro-Sequencing
5.3.5. SMRT
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global NGS Services Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. NGS Services Market Size and Volume Forecast by Application
6.3.1. Oncology
6.3.2. Lung cancer
6.3.3. Breast cancer
6.3.4. Prostate cancer
6.3.5. Colorectal cancer
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global NGS Services Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. NGS Services Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global NGS Services Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. NGS Services Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global NGS Services Demand Share Forecast, 2019-2026
9. North America NGS Services Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America NGS Services Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America NGS Services Market Size and Volume Forecast by Application
9.4.1. Oncology
9.4.2. Lung cancer
9.4.3. Breast cancer
9.4.4. Prostate cancer
9.4.5. Colorectal cancer
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America NGS Services Market Size and Volume Forecast by Type
9.7.1. SBS
9.7.2. Ion Semiconductor
9.7.3. SBL
9.7.4. Pyro-Sequencing
9.7.5. SMRT
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America NGS Services Demand Share Forecast, 2019-2026
10. Latin America NGS Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America NGS Services Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America NGS Services Market Size and Volume Forecast by Application
10.4.1. Oncology
10.4.2. Lung cancer
10.4.3. Breast cancer
10.4.4. Prostate cancer
10.4.5. Colorectal cancer
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America NGS Services Market Size and Volume Forecast by Type
10.7.1. SBS
10.7.2. Ion Semiconductor
10.7.3. SBL
10.7.4. Pyro-Sequencing
10.7.5. SMRT
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America NGS Services Demand Share Forecast, 2019-2026
11. Europe NGS Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe NGS Services Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe NGS Services Market Size and Volume Forecast by Application
11.4.1. Oncology
11.4.2. Lung cancer
11.4.3. Breast cancer
11.4.4. Prostate cancer
11.4.5. Colorectal cancer
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe NGS Services Market Size and Volume Forecast by Type
11.7.1. SBS
11.7.2. Ion Semiconductor
11.7.3. SBL
11.7.4. Pyro-Sequencing
11.7.5. SMRT
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Tye
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe NGS Services Demand Share, 2019-2026
12. Asia Pacific NGS Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific NGS Services Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific NGS Services Market Size and Volume Forecast by Application
12.4.1. Oncology
12.4.2. Lung cancer
12.4.3. Breast cancer
12.4.4. Prostate cancer
12.4.5. Colorectal cancer
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific NGS Services Market Size and Volume Forecast by Type
12.7.1. SBS
12.7.2. Ion Semiconductor
12.7.3. SBL
12.7.4. Pyro-Sequencing
12.7.5. SMRT
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific NGS Services Demand Share, 2019-2026
13. Middle East & Africa NGS Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa NGS Services Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa NGS Services Market Size and Volume Forecast by Application
13.4.1. Oncology
13.4.2. Lung cancer
13.4.3. Breast cancer
13.4.4. Prostate cancer
13.4.5. Colorectal cancer
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa NGS Services Market Size and Volume Forecast by Type
13.7.1. SBS
13.7.2. Ion Semiconductor
13.7.3. SBL
13.7.4. Pyro-Sequencing
13.7.5. SMRT
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa NGS Services Demand Share, 2019-2026
14. Competition Landscape
14.1. Global NGS Services Market: Market Share Analysis
14.2. NGS Services Distributors and Customers
14.3. NGS Services Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Beijing Genomics Institute (BGI)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cegat (Centre for Genomics and Transcriptomics) GMBH
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. DNA Vision SA
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Eurofins Genomics Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Febit / Comprehensive Biomarker Center GMBH (CBC)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Genomnia SRL
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Mina Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Macrogen Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Microsynth AG
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Seqomics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Source Bio Science
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook